These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 33217815)

  • 41. Comprehensive evaluation of FKBP10 expression and its prognostic potential in gastric cancer.
    Liang L; Zhao K; Zhu JH; Chen G; Qin XG; Chen JQ
    Oncol Rep; 2019 Aug; 42(2):615-628. PubMed ID: 31233188
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pan-cancer analysis of SERPINE1 with a concentration on immune therapeutic and prognostic in gastric cancer.
    Ju Y; Wang Z; Wang Q; Jin S; Sun P; Wei Y; Zhu G; Wang K
    J Cell Mol Med; 2024 Aug; 28(15):e18579. PubMed ID: 39086142
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Association of HOTAIR with the Diagnosis and Prognosis of Gastric Cancer and Its Effect on the Proliferation of Gastric Cancer Cells.
    Xu Z; Chen H; Yang B; Liu X; Zhou X; Kong H
    Can J Gastroenterol Hepatol; 2019; 2019():3076345. PubMed ID: 31281803
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A signature of 24 aging‑related gene pairs predict overall survival in gastric cancer.
    Zhang Y; Yan Y; Ning N; Shen Z; Ye Y
    Biomed Eng Online; 2021 Apr; 20(1):35. PubMed ID: 33823856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer Based on Bioinformatic Analysis.
    Lin Y; Zhang L; Zhang X; Wei X; Liu X; Xie Y; Han G
    J Environ Pathol Toxicol Oncol; 2023; 42(4):61-68. PubMed ID: 37522568
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of ARL4C as a Peritoneal Dissemination-Associated Gene and Its Clinical Significance in Gastric Cancer.
    Hu Q; Masuda T; Sato K; Tobo T; Nambara S; Kidogami S; Hayashi N; Kuroda Y; Ito S; Eguchi H; Saeki H; Oki E; Maehara Y; Mimori K
    Ann Surg Oncol; 2018 Mar; 25(3):745-753. PubMed ID: 29270876
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of a novel 10 immune-related genes signature as a prognostic biomarker panel for gastric cancer.
    Chen T; Yang C; Dou R; Xiong B
    Cancer Med; 2021 Sep; 10(18):6546-6560. PubMed ID: 34382341
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Aberrant expression of long noncoding RNA PVT1 and its diagnostic and prognostic significance in patients with gastric cancer.
    Yuan CL; Li H; Zhu L; Liu Z; Zhou J; Shu Y
    Neoplasma; 2016; 63(3):442-9. PubMed ID: 26925791
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification and verification of the molecular mechanisms and prognostic values of the cadherin gene family in gastric cancer.
    Luo S; Lin R; Liao X; Li D; Qin Y
    Sci Rep; 2021 Dec; 11(1):23674. PubMed ID: 34880371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer.
    Peng XC; Zeng Z; Huang YN; Deng YC; Fu GH
    Cancer Med; 2018 Jun; 7(6):2592-2600. PubMed ID: 29665316
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association of MUC16 Mutation With Tumor Mutation Load and Outcomes in Patients With Gastric Cancer.
    Li X; Pasche B; Zhang W; Chen K
    JAMA Oncol; 2018 Dec; 4(12):1691-1698. PubMed ID: 30098163
    [TBL] [Abstract][Full Text] [Related]  

  • 52. NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.
    Shi R; Wang L; Wang T; Xu J; Wang F; Xu M
    Med Oncol; 2014 Mar; 31(3):852. PubMed ID: 24469954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Upregulation of NPC1 and its association with poor prognosis in gastric cancer.
    Tang W; Huang J; Li G; Zhou Z; Wang Z
    Clin Transl Oncol; 2024 Oct; 26(10):2665-2673. PubMed ID: 38698279
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identifying Novel Cell Glycolysis-Related Gene Signature Predictive of Overall Survival in Gastric Cancer.
    Zhao X; Zou J; Wang Z; Li G; Lei Y
    Biomed Res Int; 2021; 2021():9656947. PubMed ID: 33791386
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical Value of lncRNA LUCAT1 Expression in Liver Cancer and its Potential Pathways.
    Jiao Y; Li Y; Ji B; Cai H; Liu Y
    J Gastrointestin Liver Dis; 2019 Dec; 28(4):439-447. PubMed ID: 31826070
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
    Guo H; Li C; Su X; Huang X
    Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
    [No Abstract]   [Full Text] [Related]  

  • 57. Low expression of CIP4 in predicting worse overall survival: A potential biomarker for laryngeal cancer.
    Fang L; Shi L; Wang W; Wu X; Hu T; Huang Y; Rao X
    PLoS One; 2021; 16(9):e0253545. PubMed ID: 34570775
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients.
    Li G; Xu J; Wang Z; Yuan Y; Li Y; Cai S; He Y
    J Cancer Res Clin Oncol; 2015 Mar; 141(3):443-52. PubMed ID: 25261987
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinically applicable 53-Gene prognostic assay predicts chemotherapy benefit in gastric cancer: A multicenter study.
    Zhu L; Wang H; Jiang C; Li W; Zhai S; Cai X; Wang X; Liao L; Tao F; Jin D; Chen G; Xia Y; Mao JH; Li B; Wang P; Hang B
    EBioMedicine; 2020 Nov; 61():103023. PubMed ID: 33069062
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature.
    Zhang C; Li D; Yu R; Li C; Song Y; Chen X; Fan Y; Liu Y; Qu X
    Front Immunol; 2021; 12():651033. PubMed ID: 34054812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.